Evidence map›Paper›PMID 41573212›Full record

ArticleFrontiers in endocrinology2025

Are

Ieva Baikstiene, Monika Duseikaite, Alvita Vilkeviciute, Martyna Juskiene, Jurgita Makstiene, Lina Poskiene, Arimantas Tamasauskas, Rasa Verkauskiene, Rasa Liutkeviciene, Birute Zilaitiene

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ieva BaikstieneInstitute of Endocrinology, Department of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Monika DuseikaiteInstitute of Neuroscience, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Alvita VilkeviciuteInstitute of Neuroscience, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Martyna JuskieneInstitute of Endocrinology, Department of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Jurgita MakstieneDepartment of Pathology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Lina PoskieneDepartment of Pathology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Arimantas TamasauskasInstitute of Neuroscience, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Rasa VerkauskieneInstitute of Endocrinology, Department of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Rasa LiutkevicieneInstitute of Neuroscience, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Birute ZilaitieneInstitute of Endocrinology, Department of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pituitary tumor-transforming gene 1 ( Objective: To evaluate the impact of Methods: case-control study included patients with PitNETs and age- and gender-matched controls. Diagnosis of PitNETs was confirmed by MRI/CT and/or histopathology. Genomic DNA was extracted from peripheral blood, and three Results: A total of 340 participants were enrolled, comprising 120 PitNET patients and 220 controls. Median age (53.5 Conclusions: Results suggest that

Indexed as

Ki-67 AntigenNeuroendocrine TumorsPituitary NeoplasmsPolymorphism, Single NucleotideSecurinTumor Suppressor Protein p53AdultAgedBiomarkers, TumorCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedBiomarkers, TumorKi-67 AntigenMAS1 protein, humanpituitary tumor-transforming protein 1, humanProto-Oncogene MasSecurinTP53 protein, humanTumor Suppressor Protein p53Ki-67p53PitNETspituitary neuroendocrine tumorPTTG1rs1895320rs2910200rs6882742

Identifiers

PMID41573212
PMCPMC12819198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.